InvestorsObserver
×
News Home

Will VBI Vaccines Inc (VBIV) Outperform the Healthcare Sector?

Monday, December 07, 2020 01:27 PM | InvestorsObserver Analysts

Mentioned in this article

Will VBI Vaccines Inc (VBIV) Outperform the Healthcare Sector?

VBI Vaccines Inc (VBIV) is near the top in its sector according to InvestorsObserver.

VBIV gets an overall rating of 65. That means it scores higher than 65% of stocks.

VBI Vaccines Inc gets a 78 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

Overall Score - 65
VBIV has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on VBIV!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With VBI Vaccines Inc Stock Today?

VBI Vaccines Inc (VBIV) stock has risen 1.25% while the S&P 500 is down -0.33% as of 1:24 PM on Monday, Dec 7. VBIV has risen $0.04 from the previous closing price of $3.21 on volume of 4,513,053 shares. Over the past year the S&P 500 is higher by 17.56% while VBIV has risen 269.32%. VBIV lost -$0.21 per share the over the last 12 months.

Click Here to get the full Stock Score Report on VBI Vaccines Inc (VBIV) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App